PGGM Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-95,854
| Closed | -$2.76M | – | 393 |
|
|
2023
Q4 | $2.76M | Sell |
95,854
-50,565
| -35% | -$1.53M | 0.04% | 245 |
|
|
2023
Q3 | $4.86M | Sell |
146,419
-84,157
| -36% | -$2.98M | 0.08% | 191 |
|
|
2023
Q2 | $8.46M | Sell |
230,576
-80,126
| -26% | -$3.12M | 0.14% | 147 |
|
|
2023
Q1 | $12.7M | Buy |
310,702
+38,908
| +14% | +$1.68M | 0.21% | 85 |
|
|
2022
Q4 | $13.9M | Buy |
271,794
+74,429
| +38% | +$3.57M | 0.24% | 76 |
|
|
2022
Q3 | $8.64M | Buy |
+197,365
| New | +$9.59M | 0.15% | 131 |
|
|
2022
Q1 | $12.4M | Hold |
209,232
| – | – | 0.06% | 245 |
|
|
2021
Q4 | $12.4M | Sell |
209,232
-286,717
| -58% | -$14.2M | 0.06% | 245 |
|
|
2021
Q3 | $21.3M | Buy |
495,949
+241,667
| +95% | +$10.7M | 0.11% | 203 |
|
|
2021
Q2 | $9.96M | Buy |
+254,282
| New | +$9.89M | 0.04% | 269 |
|
|
2021
Q1 | – | Sell |
-659,983
| Closed | -$24.3M | – | 384 |
|
|
2020
Q4 | $24.3M | Sell |
659,983
-2,925,324
| -82% | -$107M | 0.11% | 195 |
|
|
2020
Q3 | $125M | Buy |
3,585,307
+51,331
| +1% | +$1.8M | 0.65% | 47 |
|
|
2020
Q2 | $110M | Buy |
3,533,976
+5,957
| +0.2% | +$202K | 0.63% | 51 |
|
|
2020
Q1 | $109M | Sell |
3,528,019
-374,385
| -10% | -$12.8M | 0.79% | 40 |
|
|
2019
Q4 | $145M | Sell |
3,902,404
-2,496,803
| -39% | -$88.9M | 0.82% | 36 |
|
|
2019
Q3 | $218M | Hold |
6,399,207
| – | – | 1.04% | 26 |
|
|
2019
Q2 | $263M | Hold |
6,399,207
| – | – | 1.32% | 18 |
|
|
2019
Q1 | $258M | Hold |
6,399,207
| – | – | 1.32% | 19 |
|
|
2018
Q4 | $265M | Sell |
6,399,207
-14,752
| -0.2% | -$612K | 1.54% | 12 |
|
|
2018
Q3 | $268M | Hold |
6,413,959
| – | – | 1.41% | 12 |
|
|
2018
Q2 | $221M | Buy |
6,413,959
+829,126
| +15% | +$28.3M | 1.21% | 15 |
|
|
2018
Q1 | $188M | Buy |
5,584,833
+105,192
| +2% | +$3.62M | 1.06% | 18 |
|
|
2017
Q4 | $188M | Sell |
5,479,641
-60,441
| -1% | -$2.06M | 1.06% | 22 |
|
|
2017
Q3 | $188M | Buy |
5,540,082
+548,213
| +11% | +$17.6M | 0.93% | 25 |
|
|
2017
Q2 | $159M | Sell |
4,991,869
-35,709
| -0.7% | -$1.13M | 0.81% | 30 |
|
|
2017
Q1 | $163M | Sell |
5,027,578
-316,870
| -6% | -$9.99M | 0.84% | 28 |
|
|
2016
Q4 | $165M | Sell |
5,344,448
-194,836
| -4% | -$5.95M | 0.84% | 30 |
|
|
2016
Q3 | $178M | Sell |
5,539,284
-30,827
| -0.6% | -$1.03M | 0.89% | 26 |
|
|
2016
Q2 | $186M | Buy |
5,570,111
+1,297,538
| +30% | +$41.4M | 0.95% | 22 |
|
|
2016
Q1 | $120M | Buy |
4,272,573
+103,780
| +2% | +$2.96M | 0.64% | 38 |
|
|
2015
Q4 | $128M | Sell |
4,168,793
-163,960
| -4% | -$5.16M | 0.68% | 36 |
|
|
2015
Q3 | $129M | Buy |
4,332,753
+31,368
| +0.7% | +$1.01M | 0.7% | 35 |
|
|
2015
Q2 | $137M | Sell |
4,301,385
-589,539
| -12% | -$19.2M | 0.71% | 37 |
|
|
2015
Q1 | $161M | Sell |
4,890,924
-555,310
| -10% | -$17.7M | 0.77% | 40 |
|
|
2014
Q4 | $161M | Buy |
5,446,234
+76,572
| +1% | +$2.2M | 0.72% | 40 |
|
|
2014
Q3 | $151M | Buy |
5,369,662
+169,937
| +3% | +$4.77M | 0.71% | 38 |
|
|
2014
Q2 | $146M | Sell |
5,199,725
-2,895,306
| -36% | -$82.5M | 0.71% | 38 |
|
|
2014
Q1 | $247M | Buy |
8,095,031
+171,965
| +2% | +$5.13M | 1.29% | 14 |
|
|
2013
Q4 | $230M | Sell |
7,923,066
-126,729
| -2% | -$3.69M | 1.26% | 14 |
|
|
2013
Q3 | $219M | Buy |
8,049,795
+401,763
| +5% | +$10.9M | 1.28% | 16 |
|
|
2013
Q2 | $203M | Buy |
+7,648,032
| New | +$211M | 1.2% | 18 |
|
Other funds holding PFE
PGGM Investments's PFE Position: Q1 2024 in Review
PGGM Investments sold out of Pfizer (PFE) in Q1 2024, closing a stake of 95,854 shares — an estimated $2.76M sold.
PGGM Investments first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $268M in Q3 2018. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- PGGM Investments reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- PGGM Investments sold 95,854 Pfizer shares in Q1 2024, an estimated $2.76M.
- PGGM Investments first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
- PGGM Investments's Pfizer position peaked at $268M in Q3 2018.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on PGGM Investments's 13F filing for Q1 2024, filed 24 May 2024.